All Posts
Summer 2023 Community Fundraiser Highlights
This summer, CCF community members across the country united their friends, family, and neighbors through a variety of unique and…
Five for Friday – 5 ways to support Moving for the Cure
Home / Blog / [wpbb post:title] Moving for the Cure holds a special place in our hearts at CCF. It's…
Scientific Update - Bile Acids in Cholangiocarcinoma: A Potential Diagnostic Biomarker
Bile acids are the primary component of bile, a fluid that helps digest fats. In addition to aiding in digestion,…
Five for Friday – Five New Items in the CCF Store
Home / Blog / [wpbb post:title] CCF swag is a great and simple way to raise cholangiocarcinoma awareness. Whether it's…
A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
Study Name A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With…
Five for Friday – Five Community Member Spotlights
Home / Blog / [wpbb post:title] Each month, we recognize those whose contributions inspire us and who demonstrate excellence with…
Five for Friday – Five Educational Webinars
Home / Blog / [wpbb post:title] Did you know that CCF records all of the Educational Webinars and uploads them…
Patient Perspectives in Cross-Over Arms in Clinical Oncology Trials
The Cholangiocarcinoma Foundation (CCF) has released a new white paper, "Cross-over arms in oncology clinical trials: An important consideration for…
Dr. Juan Valle Named Cholangiocarcinoma Foundation's First Chief Medical Officer
The Cholangiocarcinoma Foundation announced the appointment of Dr. Juan Valle as its first Chief Medical Officer. Dr. Valle brings a…
Scientific Update – Radiation-releasing “seeds” may slow cholangiocarcinoma growth by inhibiting VEGFR2 singling
External radiation has been used to treat cancer for many years, but recent technological advances have led to a new…